Clinicopathological correlations with eGFR at LCCN diagnosis
Variable . | Baseline eGFR (mL/min/1.73 m2) . | P . |
---|---|---|
Age, y | ||
≤60 | 16 ± 15 | .04 (≤60 compared with >60) |
60-70 | 12 ± 9 | |
>70 | 11 ± 9 | |
LCCN at myeloma relapse | ||
Absent | 13 ± 12 | .73 |
Present | 15 ± 9 | |
Proteinuria, g/d | ||
≤2.0 | 12 ± 9 | .03 (>4 g/d compared with ≤4 g/d) |
2.1-4.0 | 12 ± 9 | |
>4.0 | 17 ± 16 | |
Free light chains, mg/L | ||
≤3500 | 15 ± 11 | .04 (trend test) |
3501-7000 | 14 ± 14 | |
>7000 | 11 ± 10 | |
Lactic acid dehydrogenase, U/L | ||
≤200 | 16 ± 15 | .03 (trend test) |
201-400 | 12 ± 9 | |
>400 | 11 ± 9 | |
β2-microglobulin, mg/L | ||
≤10.0 | 22 ± 17 | <.001 (trend test) |
10.1-20.0 | 12 ± 8 | |
>20.0 | 7 ± 6 | |
Bone marrow plasma cells, % | ||
≤33% | 16 ± 11 | .05 |
34-66 | 13 ± 14 | |
>66% | 11 ± 8 | |
Medulla interstitial inflammation, 0 vs 1-2+ | ||
0 | 20 ± 20 | .04 |
1 to ≥2 | 12 ± 9 | |
Giant cell reaction around casts, yes/no | ||
Absent | 16 ± 15 | .003 |
Present | 11 ± 7 | |
Cortex: highest number of casts/mm2 | ||
≤5 | 18 ± 17 | <.001 (trend test) |
5-10 | 11 ± 7 | |
>10 | 12 ± 9 | |
Cortex: mean number of casts/mm2 | ||
≤2 | 18 ± 16 | <.001 (trend test) |
2-5 | 12 ± 8 | |
>5 | 11 ± 8 | |
Medulla: highest number of casts/mm2 | ||
≤3 | 20 ± 19 | <.001 (trend test) |
3-7 | 12 ± 10 | |
>7 | 10 ± 9 | |
Medulla: mean number of casts/mm2 | ||
≤1.5 | 19 ± 18 | <.001 (trend test) |
1.5-3.0 | 13 ± 11 | |
>3.0 | 11 ± 9 |
Variable . | Baseline eGFR (mL/min/1.73 m2) . | P . |
---|---|---|
Age, y | ||
≤60 | 16 ± 15 | .04 (≤60 compared with >60) |
60-70 | 12 ± 9 | |
>70 | 11 ± 9 | |
LCCN at myeloma relapse | ||
Absent | 13 ± 12 | .73 |
Present | 15 ± 9 | |
Proteinuria, g/d | ||
≤2.0 | 12 ± 9 | .03 (>4 g/d compared with ≤4 g/d) |
2.1-4.0 | 12 ± 9 | |
>4.0 | 17 ± 16 | |
Free light chains, mg/L | ||
≤3500 | 15 ± 11 | .04 (trend test) |
3501-7000 | 14 ± 14 | |
>7000 | 11 ± 10 | |
Lactic acid dehydrogenase, U/L | ||
≤200 | 16 ± 15 | .03 (trend test) |
201-400 | 12 ± 9 | |
>400 | 11 ± 9 | |
β2-microglobulin, mg/L | ||
≤10.0 | 22 ± 17 | <.001 (trend test) |
10.1-20.0 | 12 ± 8 | |
>20.0 | 7 ± 6 | |
Bone marrow plasma cells, % | ||
≤33% | 16 ± 11 | .05 |
34-66 | 13 ± 14 | |
>66% | 11 ± 8 | |
Medulla interstitial inflammation, 0 vs 1-2+ | ||
0 | 20 ± 20 | .04 |
1 to ≥2 | 12 ± 9 | |
Giant cell reaction around casts, yes/no | ||
Absent | 16 ± 15 | .003 |
Present | 11 ± 7 | |
Cortex: highest number of casts/mm2 | ||
≤5 | 18 ± 17 | <.001 (trend test) |
5-10 | 11 ± 7 | |
>10 | 12 ± 9 | |
Cortex: mean number of casts/mm2 | ||
≤2 | 18 ± 16 | <.001 (trend test) |
2-5 | 12 ± 8 | |
>5 | 11 ± 8 | |
Medulla: highest number of casts/mm2 | ||
≤3 | 20 ± 19 | <.001 (trend test) |
3-7 | 12 ± 10 | |
>7 | 10 ± 9 | |
Medulla: mean number of casts/mm2 | ||
≤1.5 | 19 ± 18 | <.001 (trend test) |
1.5-3.0 | 13 ± 11 | |
>3.0 | 11 ± 9 |